foxo4-dri senolytic peptide human trial

foxo4-dri senolytic peptide human trial Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment FOX04-DRI - Apollo Peptide Sciences

Name: foxo4-dri senolytic peptide human trial Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment FOX04-DRI - Apollo Peptide Sciences
Brand: iglepidom.org
SKU: 67474081064
Price: 24.42 USD
Availability: InStock
Rating: 4.2169 (17 reviews)

FOX04 DRI Apollo Peptide Sciences Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry FOXO4 DRI Peptide Nationwide Peptides By National Science Labs, LLC The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications

SKU: 67474081064 · From iglepidom.org

4.2

USD24.42 USD53.42

Pay in 4 interest-free payments of $6.11 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 5 - Aug 10

Description

Efficacy of invasive and non-invasive brain modulation interventions for addiction

These quality specifications ensure the reconstitution solvent does not introduce endotoxin, microbial, particulate, or chemical contamination into reconstituted research compound solutions